Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ÆÄ¸Ó½´Æ¼Äà > ½Å¾à°³¹ß > ÇåÆÃÅϺ´À» À§ÇÑ ¾àÁ¦ °³¹ß : Ȱ¹ßÇÑ ÆÄÀÌÇÁ¶óÀο¡¼­ÀÇ Èñ¸Á°ú ±âȸ
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4931)
°¨¿°Áúȯ (349)
°ñÁúȯ Ä¡·á (38)
´ç´¢º´ (194)
¹é½Å (181)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (44)
ºñó¹æ ÀǾàǰ (152)
¼öÀÇÇÐ (17)
½Å°æÁúȯ (174)
½Å¾à°³¹ß (1529)
¾ÏÄ¡·á (941)
¾à¹°Àü´Þ (185)
ÀǾàǰ ±ÔÁ¦È¯°æ (127)
Á¤½ÅÁúȯ (86)
Á¦³×¸¯ ÀǾàǰ (128)
Á¦¾àȸ»çºÐ¼® (523)
󹿾à (165)
½ÃÀ庸°í¼­

ÇåÆÃÅϺ´À» À§ÇÑ ¾àÁ¦ °³¹ß : Ȱ¹ßÇÑ ÆÄÀÌÇÁ¶óÀο¡¼­ÀÇ Èñ¸Á°ú ±âȸ

Special Report: Huntington's Disease Drug Development--Hope and Opportunity in an Active Pipeline

¸®¼­Ä¡»ç Decision Resources, Inc.
¹ßÇàÀÏ 2010³â 06¿ù »óǰÄÚµå 121858
ÆäÀÌÁö Á¤º¸ 32 Pages
°¡°Ý
US $ 9,200 £Ü 10,961,800 PDF by E-mail (Global License)


Decision Resources, Inc. ¿¡¼­ 2010³â 06¿ù ¿¡ ¹ßÇàÇÑ ¡¸ÇåÆÃÅϺ´À» À§ÇÑ ¾àÁ¦ °³¹ß : Ȱ¹ßÇÑ ÆÄÀÌÇÁ¶óÀο¡¼­ÀÇ Èñ¸Á°ú ±âȸ¡¹ º¸°í¼­´Â 32 Pages·Î ±¸¼ºµÇ¾î, US $9,200 ºÎÅÍ ±¸¸Å °¡´ÉÇÕ´Ï´Ù.

Çѱ۸ñÂ÷

¹Ì±¹ ¹× À¯·´ÀÇ ÇåÆÃÅϺ´(HD : Huntington''s Disease) ȯÀÚ µ¿Çâ, ÇåÆÃÅϺ´ÀÇ º´ÀÎ, Áõ»ó, ÇöÀçÀÇ Ä¡·á¹ý ¹× »õ·Î¿î Ä¡·á¹ý, 2009³â ¹Ì±¹ÀÇ ÇåÆÃÅϺ´ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

    1. °³¿ä
    2. ¼­·Ð
    3. ÇåÆÃÅϺ´(HD : Huntington''s Disease)ÀÇ °³¿ä
    • ¹ßÁõ, Áõ»ó, Áø´Ü
    • ÇåÆÃÅϺ´ÀÇ À¯ÀüÀÚÇÐ
    • º´Å»ý¸®ÇÐ
    4. ¿ªÇÐ
    5. ÇöÀçÀÇ Ä¡·á¹ý
    • ¿îµ¿Àå¾Ö °ü¸®¸¦ À§ÇÑ Ä¡·á¹ý
    • ÇൿÇÐÀû Çö»ó(Behavioral Manifestations)À» À§ÇÑ Ä¡·á¹ý
    6. »õ·Î¿î Ä¡·á¹ý
    • Disease-Modifying Therapies
    • Symptomatic Therapies
    7. ÇâÈÄ Àü¸Á
    8. ºÎ·ÏA : Èñ±Í ÀǾàǰ(Orphan Drug)ÀÇ ¿¬±¸°³¹ß, ¸¶ÄÉÆÃ¿¡ ´ëÇÑ Àå·Á ÇÁ·Î±×·¥
    • FDA
    • À¯·´ ÀǾ౹
    • ¹Î°£Á¶Á÷ÀÇ Àμ¾Æ¼ºê
    9. ºÎ·ÏB : Âü°íÁ¤º¸
    10. ºÎ·ÏB : Àü¹®°¡ ÀÎÅͺä
LSH
Back to Top